BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2339757)

  • 1. [Morphofunctional characteristics of the uterus in dystrophic changes and necrosis in leiomyoma].
    Zheleznov BI; Brumshteĭn LM
    Akush Ginekol (Mosk); 1990 Feb; (2):21-4. PubMed ID: 2339757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor necrosis factor in uterine leiomyomas at various stages of tumor growth].
    Wolańska M; Taudul E; Bańkowska-Guszczyn E; Kinalski M
    Ginekol Pol; 2010 Jun; 81(6):431-4. PubMed ID: 20695192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Tumor factor" in uterine myoma (uterine myoma as an active component of the tumor-uterus system)].
    Savitskiĭ GA; Morozov VV; Svechnikova FA
    Akush Ginekol (Mosk); 1980 Jan; (1):35-7. PubMed ID: 7377475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
    Zhang ZL; Zhang Y; Xu BQ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androstenedione metabolism in human uterine tissues: endometrium, myometrium and leiomyoma.
    Jasonni VM; Bonavia M; Lodi S; Preti S; Bulletti C; Flamigni C
    J Steroid Biochem; 1982 Nov; 17(5):547-51. PubMed ID: 7176646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy features of uterine leiomyomas.
    Celik O; Sarac K; Hascalik S; Alkan A; Mizrak B; Yologlu S
    Gynecol Obstet Invest; 2004; 58(4):194-201. PubMed ID: 15286450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macro-microscopic changes in the uterine tube in uterine myoma].
    Brodskiĭ GV
    Morfologiia; 1999; 116(5):65-8. PubMed ID: 10581578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle architecture in uterine leiomyomas and 5-hydroxytryptamine type 2A receptor.
    Pieralli A; Andersson KL; Bussani C; Fambrini M
    Int J Gynaecol Obstet; 2008 Dec; 103(3):261-2. PubMed ID: 18775534
    [No Abstract]   [Full Text] [Related]  

  • 10. Cathepsin B in human myometrium and in uterine leiomyomas at various stages of tumour growth.
    Gogiel T; Wolańska M; Galewska Z; Kinalski M; Sobolewski K; Romanowicz L
    Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():140-4. PubMed ID: 25577554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of calponin h1 in leiomyosarcoma of the uterus.
    Horiuchi A; Nikaido T; Ito K; Zhai Y; Orii A; Taniguchi S; Toki T; Fujii S
    Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
    Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs in Uterine Development, Function and Disease.
    Nothnick WB
    Adv Exp Med Biol; 2016; 886():171-189. PubMed ID: 26659492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological changes of the blood vessels of endó and myometrium due to aging, pregnancy and diseases].
    Eto K
    Igaku Kenkyu; 1975 Apr; 45(2):109-25. PubMed ID: 1239902
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding.
    Anania CA; Stewart EA; Quade BJ; Hill JA; Nowak RA
    Mol Hum Reprod; 1997 Aug; 3(8):685-91. PubMed ID: 9294852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
    Weissenbacher T; Kuhn C; Mayr D; Pavlik R; Friese K; Scholz C; Jeschke U; Ditsch N; Dian D
    Anticancer Res; 2011 Feb; 31(2):451-7. PubMed ID: 21378323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects.
    Misao R; Nakanishi Y; Fujimoto J; Tamaya T
    Gynecol Endocrinol; 1995 Dec; 9(4):317-23. PubMed ID: 8629461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of integrins and cadherins in normal human uterus and uterine leiomyomas.
    Taylor CV; Letarte M; Lye SJ
    Am J Obstet Gynecol; 1996 Aug; 175(2):411-9. PubMed ID: 8765262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEP-19 overexpression in human uterine leiomyoma.
    Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Kusakari T; Momma C; Shime H; Yagi H; Konishi M; Suzuki A; Matsumura N; Nanbu K; Fujita J; Fujii S
    Mol Hum Reprod; 2003 Nov; 9(11):709-17. PubMed ID: 14561813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol A Concentrates Preferentially in Human Uterine Leiomyoma and Induces Proliferation in Rat Myometrium.
    Othman ER; Al-Adly DM; Elgamal DA; Ghandour N; El-Sharkawy S
    Reprod Sci; 2016 Apr; 23(4):508-14. PubMed ID: 26445998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.